ARTICLE | Company News

Athena, Duke University deal

August 21, 1995 7:00 AM UTC

ATHN received exclusive worldwide rights to technology and patent rights from Duke covering the use of apolipoprotein E (ApoE) as a diagnostic test. Duke researchers have found that the presence of the ApoE4 form of the gene significantly increases the probability that a patient's dementia is caused by Alzheimer's disease. ...